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Implication for health policy/practice/research/medical education:
Resveratrol is recently introduced as an effective antioxidant agent to ameliorate various nephropathic disorders. In this study, 
oral resveratrol at high dose (50 mg/kg, gastric gavage, 28 days) neutralized AMV (5 mg/kg/d, intraperitoneally, 14 consecutive 
days) induced biochemical changes in BUN and serum creatinine in rats. Additionally, this agent prevented renal SOD and 
TGF-β1 activities while had minor preventive effects on the AMV induced tubulopathy.
Please cite this paper as: Zendeboodi S, Esmaili A, Movahed A, Fatemikia H, Jamshidi A, Nazari M, et al. The attenuative 
effects of oral resveratrol on renal changes induced by vanadium injection in rats. J Renal Inj Prev. 2019; 8(2): 127-132. DOI: 
10.15171/jrip.2019.24.
Introduction: Resveratrol (trans-3,5,4’-trihydroxystilbene) as a polyphenol with potential 
antioxidant and anti-inflammatory properties is known as an effective herbal medicine in 
different disorders in rats. 
Objectives: The present study was carried out to investigate the protective effects of oral 
consumption of resveratrol on vanadium induced renal injury in male Wistar rats.
Materials and Methods: Animals received either ammonium metavanadate (AMV, 5 mg/
kg/d, (intraperitoneally; 14 consecutive days) or resveratrol solution (10 mg/kg and 50 mg/kg, 
gastric gavage) along with AMV treatment. The last group received resveratrol alone (50 mg/
kg, gastric gavage) for 4 weeks.
Results: AMV injection caused progressive tubular damages resembling acute tubular 
necrosis. Microscopic views revealed tubular attenuation and blebbing. In addition, 
progressive peritubular congestion of the capillaries observed while no evidence of renal 
fibrosis was present in trichrome staining. Further, levels of the renal transforming growth 
factor β1 (TGF-β1) as an index of fibrosis had no difference in treated animals as compared 
with the control (13.4±1.2 versus 11.24±0.93 pg/mg protein) at the P < 0.05. However, in AMV-
treated animals receiving the higher dose of resveratrol (50 mg/kg), the renal superoxide 
dismutase (SOD) activity, showed no difference as compared with the saline-treated rats 
(42±1.3 versus 51±1.4).  
Conclusions It is evident that AMV injection had no ability to induce renal fibrosis in rats 
while it evokes renal destructive lesions based on pathological results and enzyme levels. 
Moreover, our preliminary results suggest that resveratrol in high dose (50 mg/kg) could 
confer a minor role against AMV induced renal tubular necrosis in rats due to pathological 
results.
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Introduction
Vanadium is a hard and gray metal belongs to a group of 
elements like chromium, nickel and lithium which their 
importance in humans has not been strongly accepted. 
Moreover, this is a critical finding that this agent can play 
an important role in the growth and confrontation with 
environmental toxins or carcinogens (1,2). Diarrhea, 
irregular respiration, and ataxia are the common physical 
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signs of vanadium intoxication which usually disappear 
after 48 hours in mice (3). Further, there are some reports 
indicating the inhibitory effects of the orthovanadate 
(Na3VO4) on the renal sodium-potassium pump, skeletal 
muscles and heart (4). Renal toxicity is due to the high 
accumulation of this element in animals and originated 
from its capacity to induce the oxidative stress molecules 
at the cellular level. Different agents have been used to 
protect the renal tissues against reactive oxygen species 
(ROS), one of which is resveratrol, a polyphenol present 
in the skin of grapes, blueberries, raspberries and, 
mulberries. This particular compound has been evaluated 
as a dietary supplement to counteract destructive oxidative 
stress in the human body (5). Additionally, resveratrol 
has several beneficial effects on different pathological 
conditions including hypertension, diabetes mellitus, 
inflammation and finally neuroprotection in laboratory 
animals. Researches have shown the protective role of this 
agent against renal diseases caused by oxidative stress. 
Furthermore, there is some evidence that resveratrol 
has preventive capacity on renal fibrotic process due 
to unilateral ureteral obstruction in animal studies (6). 
It is bearing in mind that subcutaneous injection of the 
ammonium metavanadate (NH4VO3 or AMV) solution 
could produce various degrees of kidney damage within 
16 days (7).
Objectives
In this preliminary study, the renal attenuative effects of 
resveratrol on the destructive properties of the AMV were 
assessed based on the enzyme changes and pathological 
malformations in different experimental groups. 
Materials and Methods 
Animals and chemicals 
Male Sprague Dawley rats were purchased from Ahvaz 
University Breeding Center, Iran. They were sexually 
mature and weighed 200-250 g. Animals were housed 
in polycarbonate cages (three animals in each) in an air-
conditioned room with free access to water and laboratory 
chow. They were kept at 20±2°C and maintained at 12 
hours light-dark cycling, starting at 7 am. AMV was 
purchased from Santa Cruz Company. Resveratrol was 
obtained from Biotivia, BioCeuticals International SrL, 
Italy. All other reagents were analytical grades from 
commercial sources.
Experimental protocol
Animals were randomly divided into five groups 
(contained 6 rats in each) for sacrificing after 28 days 
according to Table 1.
AMV was dissolved in normal saline (pH 6.7) at the 
concentration of 5 mg/mL, just before our experiment (8) 
and daily injected intraperitoneally for 14 consecutive days.
All solutions were given orally in equal volume (0.5 mL) 
10 minutes before intraperitoneal AMV injection and 
continued for 28 days. 
They were weighed at the same time (7 am) daily before 
our experiments (Figure 1) and mortalities were recorded 
for 28 days in all groups. 
At the end of the study, all rats’ weights were measured 
and the animals sacrificed under general anesthesia 
with ketamine injection (intraperitoneally). Blood 
samples collected from the heart were centrifuged at 
2000 rpm for 5 minutes and the concentrations of the 
biological parameters including serum creatinine, urea, 
sodium, and potassium were measured using an auto-
analyzer (Olympus AU800) (9). At the same time, both 
kidneys were removed rapidly and washed with the cold 
phosphate buffer saline and weighed for each animal. The 
right kidneys were kept in formaldehyde solution (10%) 
for Hematoxylin & Eosin (H&E) staining in addition to 
Masson’s trichrome for finding pulmonary abnormalities 
and fibrosis respectively while the left kidneys were 
stored at -80°C until the analysis. The processed kidney 
sections (3-µm-thick) were evaluated with a pathologist 
unaware of our experiment. Two specimens from each 
case were inspected for 5 criteria including glomerular 
appearance, cytoplasmic vacuolization, peritubular 
capillary congestion, cytoplasmic attenuation, and finally 
Table 1. Experimental protocol
Groups Treatment (IP injection)
Gastric gavage (28 
days)
Control Saline (14 days) Saline solution
Res 50 Saline (14 days) Resveratrol (50 mg/kg)
AMV (5 mg/kg) AMV (14 days) Saline solution
AMV(5 mg/kg)+Res 10 AMV (14 days) Resveratrol (10 mg/kg)
AMV(5 mg/kg)+Res 50 AMV (14 days) Resveratrol (50 mg/kg)
Abbreviations: AMV, ammonium metavanadate; Res, resveratrol.
Figure 1. Weight variation curve of rats given AMV with or without 
resveratrol, as compared to control animals. Abbreviations: Van, 
vanadium; Res, resveratrol; AMV, ammonium metavanadate.
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intra-tubular hyaline casts on a semi-quantitative score. 
Five fields in each section were examined and a score 
ranging from 0-5 was considered, while grade 0, showed 
an intact kidney and number 5, complete destruction. 
Biochemical evaluation including the superoxide 
dismutase (SOD) and transforming growth factor beta 
1 (TGF-β1) measurements were done by using standard 
kits purchased from ZellBio GmbH company (Germany) 
(Figures 2 and 3).
Kidney indices were measured by dividing the kidney 
weight (g) to the rat body weight (kg) in all groups 
(Table 2). 
Ethical issues
This project was approved by the Ethics Committee 
of Bushehr University of Medical Sciences. Prior to 
the experiment, the protocols were confirmed to be 
in accordance with the guidelines of Animal Ethics 
Committee of Bushehr University of Medical Sciences 
(IR.BPUMS.REC.1395.196).
Statistical analysis
Results are shown as means± standard deviation (SD). 
Our data was analyzed using SPSS version 16. Our data 
were analyzed using Kruskal-Wallis and Mann-Whitney 
U tests to compare the severity of damages between our 
groups. P < 0.05 was considered indicative of a statistical 
difference between them.
Results
Vanadium effects on body weight 
Daily changes in the weights of animals during our 
experiment (28 days) are shown in Figure 1. 
There were no significant differences in weight gain 
between resveratrol-treated compared with the control 
group. On the contrary, the body weight in the AMV 
group was significantly less than the control. Resveratrol 
in two doses (10 and 50 mg/kg) had a dramatic effect for 
improving the body weight in the treated group.
Effects of resveratrol on biochemical parameters and 
relative kidney weight
The concentrations of sodium, potassium, urea, creatinine, 
and relative kidney weight are presented in Table 2.
Kidney indices did not change in each group, ruling 
out fibrosis as a destructive process. In the resveratrol 
treatment group (50 mg/kg), no alterations were observed 
compared with the control. Additionally, the serum levels 
of sodium and potassium had no statistical differences in 
our groups. Serum creatinine and urea were remarkably 
higher in AMV and AMV plus resveratrol (10 mg/kg) 
groups compared to the control, showing destructive 
nephrotic malformations. These parameters had no 
statistically significant differences compared with the 
control in AMV plus resveratrol group (50 mg/kg).
Measurement of renal SOD and TGF-β1
The levels of SOD and TGF-β1 parameters in each group 
were depicted in Figures 2 and 3. 
Values were presented as units and picogram per mg 
protein of the left kidney, respectively. AMV injection (5 
mg/kg) decreased the SOD level (P < 0.05) as compared 
with the control while it had no effects on the TGF-β1 level. 
Treatment with resveratrol solution (50 mg/kg) markedly 
increased SOD levels in the vanadium exposed animals 
while it had no effects on the TGFβ-1 level. Additionally, 
lower levels of this remedy (10 mg/kg) had no effects on 
both enzymes compared to the control.
Pathological findings
In the control samples, there were no specific pathological 
deteriorations or changes in glomeruli, tubules, interstitial 
tissues and/or peritubular capillaries in H&E staining. On 
the contrary, microscopic views of the vanadium treated 
rats in high power field (×100) revealed acute tubular 
Figure 2. Renal activities of SOD enzyme at days 28 in rats 
injected with AMV (14 days) and resveratrol in two doses (10 and 
50 mg/kg) compared to the saline and resveratrol alone. # Means 
significant differences versus control at P < 0.05. Abbreviations: 
Van, vanadium; Res, resveratrol; SOD, superoxide dismutase; 
AMV, ammonium metavanadate.
Figure 3. Active TGF-β amounts in different groups. Abbreviations: 
Van, vanadium; Res, resveratrol; TGF-β, transforming growth 
factor β.
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injuries including tubular dilatation and attenuation 
with cytoplasmic apical blebbing, sloughing and finally 
anisometric vacuolization. In addition, peritubular 
congestion of the capillaries was observed (Figure 4). 
The pathological views for our experimental groups are 
shown in Figure 5. 
It is evident that vanadium treatment evoked marked 
pathological differences compared with normal saline. In 
addition, resveratrol treatment in both doses (10 and 50 
mg/kg) could not ameliorate the destructive pathological 
properties induced with this agent qualitatively (Figure 5). 
Moreover, pathological views of resveratrol in two doses 
were compared with normal saline and vanadium treated 
groups (Figure 5). It shows no marked beneficial effects of 
resveratrol even in high dose treatment (50 mg/kg). 
Finally, there were no signs of renal fibrosis in vanadate-
treated samples since proliferative processes in addition 
to inflammatory and sclerotic malformations were not 
present in trichrome staining (data not shown). 
Discussion
Vanadium belongs to the trace elements and its deficiency 
makes the human body at risk of experimental stresses 
and other different dangers. Several studies have pointed 
out that the liver and kidney are the main organs of 
accumulation of this element (10). In addition, the 
renal tissue as the specific site for the accumulation and 
excretion of the heavy metals like vanadium is prone to 
nephrotoxic properties (11). Resveratrol-treated groups 
among the AMV injected rats counteracted weight changes 
(Figure 1) (12). Overall, our data were in agreement with 
the previous articles reported the significant body weight 
decline following different doses of the vanadyl sulfate in 
rats (13). Another promising finding was the rise in the 
creatinine and blood urea of the treated rats compared with 
the control (1.46±0.15 and 16.2±3.62 versus 0.64±0.09 
and 8.85±1.45). Interestingly, there were no clear changes 
in the serum sodium, potassium and kidney indices 
(Table 2), which were in agreement with the previous 
experiment in elderly rats demonstrating renal toxicities 
induced by this agent (1). It is noted that administration of 
the AMV significantly decreased the SOD activity in the 
renal tissues compared to the control (16.4±2.31 versus 
51.2±5.34 unit/mg protein). SOD and catalase are the first 
enzymes known to counteract the oxidative stress injuries 
with preventive effects on the reactive hydroxyl radical in 
Table 2. Results of kidney changes including blood urea nitrogen, creatinine, sodium, potassium and renal indices
Variables Control Res50 AMV5 AMV5+Res10 AMV5+Res50
Na (mEq/dL) 143.25±3.45 139.25±2.43 138.7±6.4 148.7±8.4 146.7±6.4
K (mEq/dL) 3.895±0.24 4.12±0.24 3.39±0.74 4.39±0.45 4.49±0.78
BUN (mg/dL) 8.85±1.45 9.21±1.45 16.2±3.62* 14.48±5.34* 9.6±3.62
Cr (mg/dL) 0.64±0.09 0.72±0.09 1.46±0.15* 1.26±0.45* 0.82±0.15
Kidney indices (g/kg) 3.25±0.74 3.17±0.64 3.34±0.48 3.41±0.62 3.16±0.37
Abbreviations: Van, vanadium; Res, resveratrol; BUN, blood urea nitrogen; Cr, creatinine; AMV, ammonium metavanadate.
Data are presented as means ± SD (n = 6). * means significant differences versus control at P < 0.05.
Figure 4. Photomictograph representative of acute tubular necrosis 
following intraperitoneal AMV injection (5 mg/kg for 14 days) in rats. 
Glomerular apparatus seems intact while cytoplasmic vacuolization, 
peritubular congestion, peritubular attenuation and finally intra-
tubular hyaline casts are present in our images.
Figure 5. Micrograph of renal sections of rats from different groups 
(10×; H&E stained). Control rats showing normal glomerular and 
tubular apparatus (A) while AMV treated rats demonstrating dilated 
tubules with normal glomerular arrangements (B). Resveratrol 
treated rats in lower dose (10 mg/kg) showing the reduced tubular 
dilatation(C) while in higher dose (50 mg/kg) had moderate changes 
compared to AMV treated rats. # and * show glomeruli and tubules 
respectively. 
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renal tissues (14). Interestingly, resveratrol treatment (50 
mg/kg) moderately elevated SOD in vanadium treated 
group, thus preventing renal dysfunction induced by ROS. 
Our results approved the mechanism by which resveratrol 
increases SOD activity against ROS (15). Importantly, 
the level of renal TGFβ1 as a marker of fibrosis had no 
statistical difference with the normal control (13.8±1.23 
versus 11.7±0.92 pg/mg protein). In inflammation, 
TGFβ1 is secreted by many cell types like macrophages. 
It has been reported that this cytokine at least has a dual 
role in wound healing and fibrogenesis (16). Further, it 
causes destructive effects on the renal tissues including 
synthesis of two types of collagen ( I and III) and other 
extracellular matrix proteins (17). It is well-known that 
glomerular injuries leading to sclerosis in addition to 
tubulointerstitial fibrosis are related to this particular 
agent (18). Based on our study, we have verified that 
AMV injection had no significant fibrotic effects in the 
renal tissues since there was no elevation in the amount 
of TGF-β1 and pathological results. Moreover, the 
pathological views revealed tubular dilation and sloughing 
of epithelial cells. In addition, tubular cell necrosis and 
cytoplasmic blebbing were present. However, no marked 
abnormalities were observed in the glomeruli. Contrary to 
the previous report (7), there was no sign of renal fibrosis 
induced by the AMV injection in trichrome staining. A 
similar conclusion was reached by the previous reports (1, 
19) which was in accordance with our results. 
Conclusions
Our results enlighten the tubular injuries induced by 
the AMV injection in rats. Furthermore, histological 
findings provide strong evidence of kidney damage with 
no fibrosis. However, oral resveratrol with high dosage 
(50 mg/kg) has a minor role to repair the kidney function 
by prevention of the oxidative renal injury making its 
effectiveness questionable. Further studies are needed to 
confirm these findings and to determine how resveratrol 
might act on the AMV induced kidney injuries.
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